Retracted: Assessment of HBV infection and inter‐host cellular responses using intrahepatic cholangiocyte organoids
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28975 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Chuan Kok Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Infectious Diseases Reference Laboratory, Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, Melbourne, Victoria, Aust…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocyte organoids (ICOs) model was evaluated for host differences in hepatitis B virus (HBV) infection, cellular responses, antiviral, and immunomodulator responses. Twelve ICOs generated from liver resections and biopsies were assessed for metabolic markers and functional HBV entry receptor expression throughout differentiation. Structural changes relevant to HBV infection were characterized using histology, confocal, and electron microscopy examinations. Optimal ICO culture conditions for HBV infection using HepAD38 (genotype D) and plasma derived HBV (genotype B & C) were described. HBV infection was confirmed using HBcAg immunostaining, qRT‐PCR (RNA, cccDNA, extracellular DNA), and ELISA (HBsAg and HBeAg). Drug response to antiviral and immunosuppressive agent, and cellular responses (interferon‐stimulated genes [ISG]) to interferon‐α and viral mimic (PolyI:C) were assessed. ICOs underwent metabolic and structural remodeling following differentiation. Optimal HBV infection was achieved in well‐differentiated ICOs using spinoculation, with time and donor dependent increase in HBV RNA, cccDNA, extracellular DNA, HBeAg, and HBsAg. Donor dependent drug‐responsiveness to entry inhibitor and JAK inhibitor was observed. Despite having a robust ISG response to interferon‐α and PolyI:C, HBV infection in ICOs did not upregulate ISGs. Human ICOs support HBV infection and replication with donor dependent variation in viral dynamics and cellular responses. These features can be utilized for development of personalized drug testing platform for antivirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Victorian Infectious Diseases Reference Laboratory, Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
- Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.
ORCID-Profile: Chuan Kok Lim
Zitieren
APA
Lim, C. K., Tran, B. M., Flanagan, D., McCartney, E., Tse, E., & Vincan, E. (2023). Retracted: Assessment of HBV infection and inter‐host cellular responses using intrahepatic cholangiocyte organoids. Journal of Medical Virology. https://doi.org/10.1002/jmv.28975
Vancouver
Lim CK, Tran BM, Flanagan D, McCartney E, Tse E, Vincan E. Retracted: Assessment of HBV infection and inter‐host cellular responses using intrahepatic cholangiocyte organoids. Journal of Medical Virology. 2023. doi:10.1002/jmv.28975
BibTeX
@article{Lim2023,
author = {Lim, Chuan Kok and Tran, Bang Manh and Flanagan, Dustin and McCartney, Erin and Tse, Edmund and Vincan, Elizabeth},
title = {Retracted: Assessment of HBV infection and inter‐host cellular responses using intrahepatic cholangiocyte organoids},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28975}
}
EUVIMED